A Role for CR2 in FDC-B Cell Interactions

  • D. Qin
  • J. Wu
  • G. F. Burton
  • A. K. Szakal
  • J. G. Tew
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 417)


If animals lack C3 or if C3 is destroyed by cobra venom factor, antibody responses are dramatically depressed1–5. Treatment of animals with mAb against CR2 or CD19, which are part of the CD19, CR2 TAPA-1 complex on B cells, also result in dramatically depressed antibody responses6–8. Furthermore, if animals are treated with a soluble construct of CR2, which will bind C3 fragments, the ability to mount a humoral response is markedly suppressed’. In addition, a recent study of CR2 knockout mice revealed that B cell expression of CR2 is required for immune responses to T-dependent antigens9. Furthermore, complement markedly lowers the threshold at which B cells respond to antigen and this effect may be attributable to the co-ligation of CR2 to BCR via the association with C3b-associated antigen10,11. It is also known that cross-linking of CR2 on the B cell by multiple C3b fragments on a carrier renders B cells more easily stimulated by mitogens including anti-μ12,13. These results suggest that CR2 is associated with an important signaling mechanism which is involved when B cells proliferate and differentiate into antibody forming cells (AFC).


Immune Complex None None Complement Receptor Follicular Dendritic Cell Costimulatory Signal 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    J.G. Tew, T.E. Mandel, and G.A. Miller, Immune retention: immunological requirements for maintaining an easily degradable antigen in vivo, Aust. J. exp. Biol. med. Sci. 57: 401–414 (1979).PubMedCrossRefGoogle Scholar
  2. 2.
    T.E. Mandel, R.P. Phipps, A. Abbot, and J.G. Tew, The follicular dendritic cell: long term antigen retention during immunity, Immunol. Rev. 53: 29–59 (1980).PubMedCrossRefGoogle Scholar
  3. 3.
    A. Berrebi, L. Bassous-Guedj, E. Vorst, S. Dagan, M. Shtalrid, and A. Freedman, Further characterization of prolymphocytic leukemia cells as a tumor of activated B cells, Am. J. Hematol. 34: 181–185 (1990).PubMedCrossRefGoogle Scholar
  4. 4.
    R. Burger, J. Gordon, G. Stevenson, G. Ramadori, B. Zanker, U. Hadding, and D. Bitter-Suermann, An inherited deficiency of the third component of complement, C3, in guinea pigs, Eur. J. lmmunol. 16: 7–11 (1986).CrossRefGoogle Scholar
  5. 5.
    E.C. Bottger, S. Metzger, D. Bitter-Suermann, G. Stevenson, S. Kleindienst, and R. Burger, Impaired humoral immune response in complement C3-deficient guinea pigs: absence of secondary antibody response, Eur. J. Immunol. 16: 1231–1235 (1986).PubMedCrossRefGoogle Scholar
  6. 6.
    B. Heyman, E.J. Wiersma, and T. Kinoshita, In vivo inhibition of the antibody response by a complement receptor-specific monoclonal antibody, J. Exp. Med. 172:665–668 (1990).Google Scholar
  7. 7.
    S. Gustaysson, T. Kinoshita, and B. Heyman, Antibodies to murine complement receptor 1 and 2 can inhibit the antibody response in vivo without inhibiting T helper cell induction, J. Immunol. 154: 6524–6528 (1995).Google Scholar
  8. 8.
    T. Hebell, J.M. Ahearn, and D.T. Fearon, Suppression of the immune response by a soluble complement receptor of B lymphocytes, Science 254: 102–105 (1991).PubMedCrossRefGoogle Scholar
  9. 9.
    D.A. Croix, J.M. Ahearn, A.M. Rosengard, S. Han, G. Kelsoe, M. Ma, and M.C. Carroll, Antibody Response to a T-dependent Antigen Requires B Cell Expression of Complement Receptors, J. Exp. Med. 183: 1857–1864 (1996).PubMedCrossRefGoogle Scholar
  10. 10.
    D.T. Fearon and R.H. Carter, The CD19/CR2/TAPA-1 complex of B lymphocytes: linking natural to acquired immunity, Annu. Rev. Immunol. 13: 127–149 (1995).PubMedCrossRefGoogle Scholar
  11. 11.
    D.T. Fearon, The CD19–CR2-TAPA-I complex, CD45 and signaling by the antigen receptor of B lymphocytes, Curs Opin. Immunol. 5: 341–348 (1993).CrossRefGoogle Scholar
  12. 12.
    G.C. Tsokos, J.D. Lambris, F.D. Finkelman, E.D. Anastassiou, and C.H. June, Monovalent ligands of complement receptor 2 inhibit whereas polyvalent ligands enhance anti-Ig-induced human B cell intracytoplasmie free calcium concentration, J. Immunol. 144: 1640–1645 (1990).PubMedGoogle Scholar
  13. 13.
    R.H. Carter and D.T. Fearon, Polymeric C3dg primes human B lymphocytes for proliferation induced by anti-IgM, J. Immunol. 143: 1755–1760 (1989).PubMedGoogle Scholar
  14. 14.
    G.F. Burton, D.H. Conrad, A.K. Szakal, and J.G. Tew, Follicular dendritic cells (FDC) and B cell co-stimulation, J. Immunol. 150: 31–38 (1993).PubMedGoogle Scholar
  15. 15.
    J.G. Tew, T.E. Mandel, and P.L. Rice, Immune elimination and immune retention: the relationship between antigen retained in the foot and the elicitation of footpad swelling, Immunology 40: 425–433 (1980).PubMedGoogle Scholar
  16. 16.
    J.G. Tew, M.H. Kosco, G.F. Burton, and A.K. Szakal, Follicular dendritic cells as accessory cells, Immunol. Rev. 117: 185–211 (1990).PubMedCrossRefGoogle Scholar
  17. 17.
    M. Yamakawa and Y. Imai, Complement activation in the follicular light zone of human lymphoid tissues. Immunology 76: 378–384 (1992).PubMedGoogle Scholar
  18. 18.
    J. Wu, D. Qin, G.F. Burton, A. Szakal, and J.G. Tew, Follicular Dendritic Cell (FDC) Derived Ag and Accessory Activity in Initiation of Memory IgG Responses in Vitro, J. Immunol. 157: (1996).Google Scholar
  19. 19.
    T. Kinoshita, J. Takeda, K. Hong, H. Kozono, H. Sakai, and K. Inoue, Monoclonal antibodies to mouse complement receptor type I (CRI). Their use in a distribution study showing that mouse erythrocytes and platelets are CR-1 negative. J. Immunol. 140: 3066 (1988).Google Scholar
  20. 20.
    S.L.T. Helm, G.F. Burton, A.K. Szakal, and J.G. Tew, Follicular dendritic cells and the maintenance of IgE responses, Eus J. Immunol. 25: 2362–2369 (1995).CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1997

Authors and Affiliations

  • D. Qin
    • 1
  • J. Wu
    • 1
  • G. F. Burton
    • 1
  • A. K. Szakal
    • 2
  • J. G. Tew
    • 1
  1. 1.Department of Microbiology and ImmunologyMedical College of Virginia Virginia Commonwealth UniversityRichmondUSA
  2. 2.Department of Anatomy, Division of ImmunobiologyMedical College of Virginia Virginia Commonwealth UniversityRichmondUSA

Personalised recommendations